These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1003 related articles for article (PubMed ID: 9739579)
1. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
3. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy]. Shigeto E; Murakami I; Yokosaki Y Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329 [TBL] [Abstract][Full Text] [Related]
4. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis]. Yoshiyama T; Ito K; Ogata H; Aono A; Wada M Kekkaku; 2005 Jan; 80(1):9-14. PubMed ID: 15839057 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
6. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases]. Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128 [TBL] [Abstract][Full Text] [Related]
7. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Al-Marri MR Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769 [TBL] [Abstract][Full Text] [Related]
8. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]. Yoshiyama T; Ogata H; Ito K; Aono A; Wada M Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318 [TBL] [Abstract][Full Text] [Related]
9. [Reasons for drug-resistant tuberculosis emergence]. Tu DH Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
11. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916 [TBL] [Abstract][Full Text] [Related]
12. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. Park SK; Kim CT; Song SD Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607 [TBL] [Abstract][Full Text] [Related]
13. [Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin]. Baba H Kekkaku; 1994 Jun; 69(6):387-96. PubMed ID: 8041057 [TBL] [Abstract][Full Text] [Related]
14. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone]. Belianin II; Shmelev EI Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039 [TBL] [Abstract][Full Text] [Related]
15. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087 [TBL] [Abstract][Full Text] [Related]
16. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Kam KM; Yip CW Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892 [TBL] [Abstract][Full Text] [Related]
17. Drug-resistant tuberculosis in Budapest. Fodor T; Vadász I; Lõrinczi I Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927 [TBL] [Abstract][Full Text] [Related]
18. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045 [TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742 [TBL] [Abstract][Full Text] [Related]
20. [The use of gene chip in detecting Mycobacterium tuberculosis resistant to rifampin and isoniazid]. Cui ZL; Jing FX; Hu ZY; Wu ZR; Zhao JL Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):439-41. PubMed ID: 15312553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]